β-Adrenergic agonists exert their 'anti-inflammatory' effects in monocytic cells through the IκB/NF-κB pathway

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 4 23-4, 2000, Pages

  Farmer, Pierre ^a   Pugin, Jérôme ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adenosine 3',5' cyclic monophosphate; I B; Lipopolysaccharide; Nuclear factor B

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR;

ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0033712736     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.4.l675     Document Type: Article

References (47)

1. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha
2. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: Synergism with prostanoids and salbutamol
3. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
4. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation
5. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB
6. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
7. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
8. Beta2-adrenergic receptor stimulation inhibits nitric oxide generation by Mycobacterium avium infected macrophages
9. Partial vs. full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol
10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun
11. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
12. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro
13. Establishment of lipopolysaccharide-dependent nuclear factor kappa B activation in a cell-free system
14. Beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists
15. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
16. Catecholamine-induced suppression of interleukin- 1 production
17. Identification of beta 2-adrenoceptors on guinea pig alveolar macrophages using (-)-3-[125I]iodocyanopindolol
18. Beta-adrenoceptor-effector system of the human macrophage U937 cell line
19. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines
20. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines
21. Modulation of interleukin-6 by beta2-adrenoceptor in endotoxin-stimulated renal macrophage cells
22. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A
23. Role of IKK 1 and IKK2 in lipopolysaccharide signaling in human monocytic cells
24. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells
25. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12
26. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription
27. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs
28. CD14-dependent endotoxin internalization via a macropinocytic pathway
29. Activation of human macrophages by mechanical ventilation in vitro
30. CD 14 is a pattern recognition receptor
31. Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14
32. TGF-beta increases leukotriene C4 synthase expression in the monocyte-like cell line, THP-1
33. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
34. Anti-inflammatory activity of salmeterol: Down-regulation of cytokine production
35. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists
36. Structural analysis of the rabbit TNF locus, containing the genes encoding TNF-beta (lymphotoxin) and TNF-alpha (tumor necrosis factor)
37. Dynamics of dibutyryl cyclic AMP-and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression
38. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP
39. Molecular pharmacology of the beta-adrenergic receptor on THP-1 cells
40. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons
41. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia
42. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood
43. IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells
44. Cyclic adenosine monophosphate decreases the secretion, but not the cell-associated levels, of interleukin-1 beta in lipopolysaccharide-activated human monocytes
45. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
46. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors
47. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I-kappaB kinase-beta